Head of Statutory Health Insurance Docs Challenges Lauterbach's COVID Alarms
A Relaxed Approach versus Urgent Warnings
Health Minister Lauterbach puts Germany on high alert, warning of a looming COVID surge. His advice includes masking up and remote work. The Head of the National Association of Statutory Health Insurance Physicians (KBV), Andreas Gassen, sees things differently.
Gassen, in an interview with the Rheinische Post newspaper, criticizes Lauterbach's approach as excessively urgent. In his view, we're no longer in a pandemic situation. Despite the sharp rise in numbers, Gassen suggests that we should not blindly follow the advice provided for common colds or flu. What's crucial, he argues, is encouraging vaccinations against both COVID-19 and influenza, particularly for older individuals and at-risk groups.
The Challenge of Vaccine Skepticism
One area of concern for Gassen is the growing skepticism towards vaccines. Regrettably, Gassen notes the low rates of flu vaccination, which he finds disheartening. He, too, understands why some people might hesitate after concerns over vaccine safety and tolerability were dismissed by medical professionals and politicians. Gassen highlights individual vaccine injuries and Long COVID cases as components of the overall picture.
Lauterbach's Warning: COVID Remains a Threat
Echoing Lauterbach's concerns, the SPD politician advises caution and increased vaccinations as Christmas approaches. COVID is still a dangerous threat, Lauterbach told the "Bild" newspaper. Besides, COVID often targets blood vessels and weakens the immune system, meaning it does not always lead to a full recovery. Lauterbach also advises people to mask up on public transportation and, if possible, to work from home instead of returning to the office.
The Debate Over COVID Precautions
Gassen's criticism of Lauterbach's warnings highlights the ongoing debate over COVID precautions. While Gassen believes that some measures may be unnecessary or disproportionate, Lauterbach emphasizes the danger of COVID and the need to take appropriate action. The debate highlights various concerns, including the balance between scientific evidence, economic impact, public trust, local control, and vaccination policies.
